| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 892.53B | 853.43B | 761.30B | 626.18B | 564.99B | 523.33B |
| Gross Profit | 252.08B | 223.79B | 198.59B | 164.95B | 151.21B | 144.79B |
| EBITDA | 79.48B | 71.98B | 52.56B | 50.83B | 49.43B | 48.77B |
| Net Income | 36.64B | 32.29B | 19.98B | 23.32B | 25.86B | 52.83B |
Balance Sheet | ||||||
| Total Assets | 626.45B | 623.81B | 547.14B | 556.90B | 326.95B | 340.18B |
| Cash, Cash Equivalents and Short-Term Investments | 92.93B | 90.12B | 69.66B | 56.82B | 51.00B | 18.51B |
| Total Debt | 98.36B | 87.61B | 45.97B | 82.18B | 42.16B | 57.10B |
| Total Liabilities | 409.01B | 415.50B | 368.22B | 395.84B | 186.85B | 195.88B |
| Stockholders Equity | 214.31B | 205.00B | 176.82B | 159.20B | 138.63B | 144.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 36.54B | 53.81B | 29.94B | 30.57B | 37.67B |
| Operating Cash Flow | 0.00 | 44.08B | 58.20B | 34.61B | 42.90B | 41.70B |
| Investing Cash Flow | 0.00 | -37.17B | -14.13B | -81.26B | 12.89B | -6.61B |
| Financing Cash Flow | 0.00 | 23.86B | -45.80B | 30.62B | -23.83B | -34.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥27.91B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
71 Outperform | ¥335.85B | 8.84 | ― | 1.35% | 15.92% | 52.76% | |
66 Neutral | ¥296.92B | 14.98 | 11.17% | 2.61% | 5.63% | 25.64% | |
65 Neutral | ¥226.22B | 18.16 | ― | 2.23% | 3.24% | 12.49% | |
64 Neutral | ¥455.14B | 9.24 | 4.18% | 2.57% | 1.26% | 14.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥259.55B | 19.39 | ― | 2.72% | 2.23% | 57.10% |